1. Home
  2. LOT vs ABCL Comparison

LOT vs ABCL Comparison

Compare LOT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOT
  • ABCL
  • Stock Information
  • Founded
  • LOT 1948
  • ABCL 2012
  • Country
  • LOT China
  • ABCL Canada
  • Employees
  • LOT N/A
  • ABCL N/A
  • Industry
  • LOT
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOT
  • ABCL Health Care
  • Exchange
  • LOT NYSE
  • ABCL Nasdaq
  • Market Cap
  • LOT 956.3M
  • ABCL 772.9M
  • IPO Year
  • LOT N/A
  • ABCL 2020
  • Fundamental
  • Price
  • LOT $2.12
  • ABCL $2.13
  • Analyst Decision
  • LOT
  • ABCL Strong Buy
  • Analyst Count
  • LOT 0
  • ABCL 4
  • Target Price
  • LOT N/A
  • ABCL $8.33
  • AVG Volume (30 Days)
  • LOT 173.5K
  • ABCL 4.1M
  • Earning Date
  • LOT 06-10-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • LOT N/A
  • ABCL N/A
  • EPS Growth
  • LOT N/A
  • ABCL N/A
  • EPS
  • LOT N/A
  • ABCL N/A
  • Revenue
  • LOT $924,349,000.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • LOT $40.53
  • ABCL N/A
  • Revenue Next Year
  • LOT $87.99
  • ABCL $36.62
  • P/E Ratio
  • LOT N/A
  • ABCL N/A
  • Revenue Growth
  • LOT 36.13
  • ABCL N/A
  • 52 Week Low
  • LOT $1.06
  • ABCL $1.89
  • 52 Week High
  • LOT $13.50
  • ABCL $4.20
  • Technical
  • Relative Strength Index (RSI)
  • LOT 59.03
  • ABCL 45.42
  • Support Level
  • LOT $1.99
  • ABCL $1.98
  • Resistance Level
  • LOT $2.17
  • ABCL $2.08
  • Average True Range (ATR)
  • LOT 0.17
  • ABCL 0.10
  • MACD
  • LOT -0.02
  • ABCL 0.01
  • Stochastic Oscillator
  • LOT 53.66
  • ABCL 48.15

About LOT LOTUS TECHNOLOGY INC

Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: